Patent classifications
A23P10/40
PERFORMANCE ENHANCEMENT DELIVERY SYSTEM
The present disclosure provides an improvement of existing L-arginine containing supplements by providing both hydrogen crystals (H.sub.2) and co-enzyme Q10 (Co-Q10) to produce a nutrient formulation, including compositions containing said formulation and methods of administering such formulation.
PERFORMANCE ENHANCEMENT DELIVERY SYSTEM
The present disclosure provides an improvement of existing L-arginine containing supplements by providing both hydrogen crystals (H.sub.2) and co-enzyme Q10 (Co-Q10) to produce a nutrient formulation, including compositions containing said formulation and methods of administering such formulation.
POWDERED PROCESSED SESAME PRODUCT AND METHOD FOR PRODUCING SAME
To provide a powdered processed sesame product with a reduced fat and oil content and excellent handleability, while the flavor of paste sesame is retained, and a method for producing the same. A processed sesame product according to the present invention is a powdered processed sesame product containing a ground product of sesame, and the ground product of sesame has an oil content of smaller than 30% by mass relative to the total mass of the ground product and has a 10% cumulative diameter of 30 μm or smaller and preferably 20 μm or smaller and a 50% cumulative diameter of 70 μm or larger, and the processed sesame product has a good balance of the paste sesame feel, the strength of flavor, and the strength of taste.
POWDERED PROCESSED SESAME PRODUCT AND METHOD FOR PRODUCING SAME
To provide a powdered processed sesame product with a reduced fat and oil content and excellent handleability, while the flavor of paste sesame is retained, and a method for producing the same. A processed sesame product according to the present invention is a powdered processed sesame product containing a ground product of sesame, and the ground product of sesame has an oil content of smaller than 30% by mass relative to the total mass of the ground product and has a 10% cumulative diameter of 30 μm or smaller and preferably 20 μm or smaller and a 50% cumulative diameter of 70 μm or larger, and the processed sesame product has a good balance of the paste sesame feel, the strength of flavor, and the strength of taste.
ULTRAVIOLET TREATMENT OF TRANSFORMED COLEOPTERA LARVAE FOR VITAMIN D3 ENRICHMENT
The present invention relates to a process for preparing a beetle powder comprising a light treatment step in which at least one light source emits ultraviolet radiation toward transformed beetle larvae.
ULTRAVIOLET TREATMENT OF TRANSFORMED COLEOPTERA LARVAE FOR VITAMIN D3 ENRICHMENT
The present invention relates to a process for preparing a beetle powder comprising a light treatment step in which at least one light source emits ultraviolet radiation toward transformed beetle larvae.
Spray-dried 3-fucosyllactose
Disclosed is a method for the manufacture of a spray-dried powder consisting essentially of 3-fucosyllactose, the spray-dried powder, its use for the manufacture of nutritional compositions, and nutritional compositions containing the spray-dried powder.
Spray-dried 3-fucosyllactose
Disclosed is a method for the manufacture of a spray-dried powder consisting essentially of 3-fucosyllactose, the spray-dried powder, its use for the manufacture of nutritional compositions, and nutritional compositions containing the spray-dried powder.
Stable dry powders and emulsions containing probiotics
Compositions and methods for mucosal delivery of agents are provided. The emulsion compositions are intended for administration to a mucosal surface, such as oral, gastrointestinal and nasal mucosa. The emulsion compositions provided contain one or more mucoadhesive proteins and an agent to be delivered. Methods for delivery of agents using the compositions provided herein are also provided.
Stable dry powders and emulsions containing probiotics
Compositions and methods for mucosal delivery of agents are provided. The emulsion compositions are intended for administration to a mucosal surface, such as oral, gastrointestinal and nasal mucosa. The emulsion compositions provided contain one or more mucoadhesive proteins and an agent to be delivered. Methods for delivery of agents using the compositions provided herein are also provided.